These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chancroid. Recent advances in treatment and control. Ronald AR Int J Dermatol; 1986; 25(1):31-3. PubMed ID: 3485081 [No Abstract] [Full Text] [Related]
3. Treatment of chancroid. J Am Acad Dermatol; 1983 Jan; 8(1):128-32. PubMed ID: 6600752 [No Abstract] [Full Text] [Related]
4. Drug of choice for chancroid. Sturm AW; Zanen HC Lancet; 1983 Jan; 1(8316):125. PubMed ID: 6129437 [No Abstract] [Full Text] [Related]
5. Chancroid and Haemophilus ducreyi. Ronald AR; Plummer FA Ann Intern Med; 1985 May; 102(5):705-7. PubMed ID: 3872617 [No Abstract] [Full Text] [Related]
6. In vitro susceptibility of Haemophilus ducreyi to several antibiotics. Ismaeel NA Microbios; 1993; 74(299):103-9. PubMed ID: 8361391 [TBL] [Abstract][Full Text] [Related]
7. Drug resistance of Haemophilus ducreyi. Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585 [TBL] [Abstract][Full Text] [Related]
8. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda. Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Ison CA; Dillon JA; Tapsall JW Lancet; 1998; 351 Suppl 3():8-11. PubMed ID: 9652713 [No Abstract] [Full Text] [Related]
10. Haemophilus ducreyi is resistant to human antimicrobial peptides. Mount KL; Townsend CA; Bauer ME Antimicrob Agents Chemother; 2007 Sep; 51(9):3391-3. PubMed ID: 17620373 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390 [TBL] [Abstract][Full Text] [Related]
12. UK National Guideline for the management of Chancroid 2014. O'Farrell N; Lazaro N Int J STD AIDS; 2014 Dec; 25(14):975-83. PubMed ID: 25080286 [No Abstract] [Full Text] [Related]
13. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi. Wall RA; Mabey DC; Bello CS; Felmingham D J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717 [TBL] [Abstract][Full Text] [Related]
14. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya. Plummer FA; Maggwa N; D'Costa LJ; Nsanze H; Karasira P; Maclean IW; Ronald AR Sex Transm Dis; 1984; 11(4):304-7. PubMed ID: 6098034 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi. Aldridge KE; Cammarata C; Martin DH Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617 [TBL] [Abstract][Full Text] [Related]
19. Single-dose therapy of chancroid with trimethoprim-sulfametrole. Plummer FA; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Ellison RH; Ronald AR N Engl J Med; 1983 Jul; 309(2):67-71. PubMed ID: 6343878 [TBL] [Abstract][Full Text] [Related]
20. Chancroid - desperate patient makes own diagnosis. Barnes P; Chauhan M Int J STD AIDS; 2014 Sep; 25(10):768-70. PubMed ID: 24535694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]